Market Closed -
Bombay S.E.
06:12:56 2024-05-02 EDT
|
5-day change
|
1st Jan Change
|
11,408
INR
|
+0.06%
|
|
+18.75%
|
+34.31%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
17,852
|
19,594
|
21,843
|
29,132
|
34,471
|
67,336
|
Enterprise Value (EV)
1 |
16,019
|
17,758
|
19,404
|
26,344
|
30,487
|
61,596
|
P/E ratio
|
27.1
x
|
39.5
x
|
35.4
x
|
43.6
x
|
35.3
x
|
49
x
|
Yield
|
0.2%
|
0.2%
|
0.18%
|
0.14%
|
0.11%
|
0.06%
|
Capitalization / Revenue
|
4.36
x
|
4.97
x
|
5.7
x
|
5.58
x
|
5.35
x
|
9.83
x
|
EV / Revenue
|
3.91
x
|
4.51
x
|
5.06
x
|
5.04
x
|
4.73
x
|
8.99
x
|
EV / EBITDA
|
24.3
x
|
32.9
x
|
27.5
x
|
33.5
x
|
26.7
x
|
41.1
x
|
EV / FCF
|
304
x
|
45.6
x
|
40.2
x
|
266
x
|
49.1
x
|
56
x
|
FCF Yield
|
0.33%
|
2.19%
|
2.49%
|
0.38%
|
2.04%
|
1.79%
|
Price to Book
|
5.27
x
|
5.1
x
|
4.95
x
|
5.77
x
|
5.76
x
|
9.2
x
|
Nbr of stocks (in thousands)
|
7,928
|
7,928
|
7,928
|
7,928
|
7,928
|
7,928
|
Reference price
2 |
2,252
|
2,472
|
2,755
|
3,675
|
4,348
|
8,494
|
Announcement Date
|
19-04-13
|
20-06-26
|
21-04-10
|
22-04-15
|
23-04-17
|
24-04-13
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
4,094
|
3,941
|
3,833
|
5,222
|
6,449
|
6,852
|
EBITDA
1 |
657.9
|
540.2
|
705.3
|
786.2
|
1,142
|
1,498
|
EBIT
1 |
605.4
|
480.8
|
602.9
|
681.1
|
1,035
|
1,383
|
Operating Margin
|
14.79%
|
12.2%
|
15.73%
|
13.04%
|
16.05%
|
20.19%
|
Earnings before Tax (EBT)
1 |
891.6
|
637.9
|
802.1
|
913.8
|
1,291
|
1,836
|
Net income
1 |
657.8
|
495.6
|
617.6
|
668.8
|
977.8
|
1,373
|
Net margin
|
16.07%
|
12.58%
|
16.12%
|
12.81%
|
15.16%
|
20.04%
|
EPS
2 |
82.98
|
62.52
|
77.91
|
84.36
|
123.3
|
173.2
|
Free Cash Flow
1 |
52.65
|
389.1
|
482.6
|
98.87
|
620.7
|
1,101
|
FCF margin
|
1.29%
|
9.87%
|
12.59%
|
1.89%
|
9.63%
|
16.07%
|
FCF Conversion (EBITDA)
|
8%
|
72.02%
|
68.41%
|
12.58%
|
54.34%
|
73.5%
|
FCF Conversion (Net income)
|
8%
|
78.5%
|
78.13%
|
14.78%
|
63.48%
|
80.18%
|
Dividend per Share
2 |
4.500
|
5.000
|
5.000
|
5.000
|
5.000
|
5.000
|
Announcement Date
|
19-04-13
|
20-06-26
|
21-04-10
|
22-04-15
|
23-04-17
|
24-04-13
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,833
|
1,836
|
2,439
|
2,788
|
3,984
|
5,740
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
52.6
|
389
|
483
|
98.9
|
621
|
1,101
|
ROE (net income / shareholders' equity)
|
21.3%
|
13.7%
|
15%
|
14.1%
|
17.7%
|
20.6%
|
ROA (Net income/ Total Assets)
|
9.92%
|
6.9%
|
7.59%
|
7.37%
|
9.68%
|
10.8%
|
Assets
1 |
6,633
|
7,186
|
8,135
|
9,072
|
10,097
|
12,687
|
Book Value Per Share
2 |
428.0
|
484.0
|
557.0
|
637.0
|
755.0
|
923.0
|
Cash Flow per Share
2 |
2.840
|
7.360
|
15.00
|
4.410
|
7.390
|
4.070
|
Capex
1 |
232
|
125
|
166
|
111
|
74.3
|
124
|
Capex / Sales
|
5.66%
|
3.18%
|
4.34%
|
2.13%
|
1.15%
|
1.8%
|
Announcement Date
|
19-04-13
|
20-06-26
|
21-04-10
|
22-04-15
|
23-04-17
|
24-04-13
|
|
1st Jan change
|
Capi.
|
---|
| +34.31% | 1.08B | | +14.32% | 64.32B | | -3.80% | 45.95B | | +13.69% | 39.61B | | +20.84% | 25.74B | | +8.66% | 18.75B | | +0.65% | 17.23B | | -21.03% | 15.86B | | +0.81% | 15.03B | | -13.28% | 13.99B |
Other Specialty Chemicals
|